For patients with rheumatic disease and hepatitis C infection: the end of interferon | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Infectious diseases

Viewpoint

For patients with rheumatic disease and hepatitis C infection: the end of interferon

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Calabrese LH, Cacoub PP

For patients with rheumatic disease and hepatitis C infection: the end of interferon

RMD Open 2015;1:e000008. doi: 10.1136/rmdopen-2014-000008